Skip to content
Institutional Investor early-stage mid-stage Est. 2000

Harbinger Venture Capital

Early stage corporate VC firm investing in North America & Asia

📍 Taipei, Taiwan

About This Fund

Harbinger Venture Management is early stage corporate venture capital arm of MiTAC-SYNNEX Group that makes investments in North America & Asia. It invests across multiple sectors engaged in the areas such as Semiconductor, Wireless, LED Technology, Photonics, Medical Devices, BioPharma, Social, Digital Media. Notable portfolio companies are Envivio, Cardival Medical, Crown Bioscience, Yeepay, Applied Optoelectronics etc. The firm typically invests between $1M to $5 M per company.

Investment Focus

Sectors
Next Gen Computing & Communication Innovative Precision Instruments Biomedical Novel Materials Disruptive Services & Enablers Mobility Redefined Legacy Reinvented Green Energy
Stages
early-stage mid-stage
Check Size $1M-$8M
Geography
USA China

What They Look For

Startups optimizing opportunities between Greater China and USA; promising teams; high-tech startups or niche high-growth companies

Preparing to pitch Harbinger Venture Capital?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →